Human Anti-Human Complement C9 Monoclonal Antibody (CTJS-106)(Cat#: CTA-062)

Name: Human Anti-Human Complement C9 Monoclonal Antibody (CTJS-106)
SKU: CTA-062
Rating: 5 (1 reviews)

This product is an unconjugated anti-Human Complement C9 Monoclonal antibody (CTJS-106) generated from the Human. The antibody can be used for WB; FC; IA; IF; IHC.

INQUIRY

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP

Summary Related Products & Services

Specifications

Clonality	Monoclonal
Clone	CTJS-106
Host Animal	Human
Isotype	IgG1
Immunogen	Neoepitope on the 61 kDa complement component C9, integrated in the terminal complement complex (TCC)
Species Reactivity	Human
Applications	WB; FC; IA; IF; IHC
Application Notes	WB: 1:100-1:2000 FC: 1:10-1:1000 IF: 1:10-1:500 IHC: 1:10-1:500 The optimal working dilutions should be determined by the end user.
Specificity	This antibody reacts with Human complement C9.
Purity	≥95% as determined by SDS-PAGE
Format	Liquid
Size	25; 100 µg
Storage	4°C
Type	Primary Antibody

Target

Target Name	C9
Alternative Names	Complement Component 9; Complement C9 ; ARMD15; C9D
Gene ID	735
UniProt ID	P02748

Information

Introduction

Complement component 9 is a protein involved in the complement system, which is part of the innate immune system. It is a member of the complement membrane attack complex (MAC) and induces pores on cell membranes, causing lysis. There are 10-16 molecules of C9 in a single membrane attack complex (MAC), along with one of each of the complement components C5b, C6, C7 and C8.

For Research Use Only. Not for Diagnostic or Therapeutic Applications.